Search results
RBC Capital lifts Moderna shares target, highlights RSV vaccine approval By Investing.com
Investing.com· 2 days agoOn Monday, RBC (TSX:RY) Capital Markets adjusted its outlook on Moderna (NASDAQ:MRNA) shares,...
Moderna just got FDA approval for its RSV vaccine — only its second product on the market
Quartz· 4 days agoThe Food and Drug Administration on Friday approved Moderna’s mRNA-based respiratory syncytial virus...
The U.S. Is Close To Bankrolling Moderna's Bird Flu Vaccine As Third Dairy Worker Tests Positive
Investor's Business Daily· 5 days agoModerna stock seesawed Thursday after confirming the U.S. government is nearing a deal to fund its...
Option Trade On Volatile Moderna Stock Could Return 28% By Mid-July
Investor's Business Daily· 6 days agoThis can be a welcome change for buy-and-hold investors who are reliant on markets always going up....
Moderna Receives U.S. FDA Approval for RSV Vaccine mRESVIA(R)
The Joplin Globe· 4 days agomRESVIA is Moderna's second approved product and the only RSV vaccine available in single-dose pre-filled syringes
Moderna-Merck skin cancer vaccine shows survival benefit in long-term follow-up
Reuters via Yahoo News· 2 days agoDetailed data on Monday from the 157-patient trial showed that after two and a half years, melanoma...
US nears deal to fund Moderna's bird flu vaccine trial, FT reports
Reuters· 6 days ago, opens new tab mRNA bird flu vaccine, the Financial Times reported on Thursday, as the outbreak...
Moderna's mRNA bird flu vaccine trial is close to getting U.S. government funding
Quartz· 5 days agoThe U.S. government is close to finalizing a deal to fund a late-stage trial of Moderna’s mRNA H5N1...
Moderna Scores FDA Approval For Its Second Product - Respiratory Syncytial Virus Vaccine
Benzinga via Yahoo Finance· 4 days agoOn Friday, the FDA approved Moderna Inc’s (NASDAQ:MRNA) mRESVIA (mRNA-1345), an mRNA respiratory...
Moderna (NASDAQ:MRNA) Stock Price Down 6.2%
ETF DAILY NEWS· 6 days agoModerna, Inc. (NASDAQ:MRNA – Get Free Report) shares fell 6.2% during trading on Tuesday . The company traded as low as $156.15 and last traded at $156.26. 873,085 shares ...